Cargando…

Predicting drug-disease associations by using similarity constrained matrix factorization

BACKGROUND: Drug-disease associations provide important information for the drug discovery. Wet experiments that identify drug-disease associations are time-consuming and expensive. However, many drug-disease associations are still unobserved or unknown. The development of computational methods for...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wen, Yue, Xiang, Lin, Weiran, Wu, Wenjian, Liu, Ruoqi, Huang, Feng, Liu, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006580/
https://www.ncbi.nlm.nih.gov/pubmed/29914348
http://dx.doi.org/10.1186/s12859-018-2220-4
_version_ 1783332864205520896
author Zhang, Wen
Yue, Xiang
Lin, Weiran
Wu, Wenjian
Liu, Ruoqi
Huang, Feng
Liu, Feng
author_facet Zhang, Wen
Yue, Xiang
Lin, Weiran
Wu, Wenjian
Liu, Ruoqi
Huang, Feng
Liu, Feng
author_sort Zhang, Wen
collection PubMed
description BACKGROUND: Drug-disease associations provide important information for the drug discovery. Wet experiments that identify drug-disease associations are time-consuming and expensive. However, many drug-disease associations are still unobserved or unknown. The development of computational methods for predicting unobserved drug-disease associations is an important and urgent task. RESULTS: In this paper, we proposed a similarity constrained matrix factorization method for the drug-disease association prediction (SCMFDD), which makes use of known drug-disease associations, drug features and disease semantic information. SCMFDD projects the drug-disease association relationship into two low-rank spaces, which uncover latent features for drugs and diseases, and then introduces drug feature-based similarities and disease semantic similarity as constraints for drugs and diseases in low-rank spaces. Different from the classic matrix factorization technique, SCMFDD takes the biological context of the problem into account. In computational experiments, the proposed method can produce high-accuracy performances on benchmark datasets, and outperform existing state-of-the-art prediction methods when evaluated by five-fold cross validation and independent testing. CONCLUSION: We developed a user-friendly web server by using known associations collected from the CTD database, available at http://www.bioinfotech.cn/SCMFDD/. The case studies show that the server can find out novel associations, which are not included in the CTD database.
format Online
Article
Text
id pubmed-6006580
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60065802018-06-26 Predicting drug-disease associations by using similarity constrained matrix factorization Zhang, Wen Yue, Xiang Lin, Weiran Wu, Wenjian Liu, Ruoqi Huang, Feng Liu, Feng BMC Bioinformatics Research Article BACKGROUND: Drug-disease associations provide important information for the drug discovery. Wet experiments that identify drug-disease associations are time-consuming and expensive. However, many drug-disease associations are still unobserved or unknown. The development of computational methods for predicting unobserved drug-disease associations is an important and urgent task. RESULTS: In this paper, we proposed a similarity constrained matrix factorization method for the drug-disease association prediction (SCMFDD), which makes use of known drug-disease associations, drug features and disease semantic information. SCMFDD projects the drug-disease association relationship into two low-rank spaces, which uncover latent features for drugs and diseases, and then introduces drug feature-based similarities and disease semantic similarity as constraints for drugs and diseases in low-rank spaces. Different from the classic matrix factorization technique, SCMFDD takes the biological context of the problem into account. In computational experiments, the proposed method can produce high-accuracy performances on benchmark datasets, and outperform existing state-of-the-art prediction methods when evaluated by five-fold cross validation and independent testing. CONCLUSION: We developed a user-friendly web server by using known associations collected from the CTD database, available at http://www.bioinfotech.cn/SCMFDD/. The case studies show that the server can find out novel associations, which are not included in the CTD database. BioMed Central 2018-06-19 /pmc/articles/PMC6006580/ /pubmed/29914348 http://dx.doi.org/10.1186/s12859-018-2220-4 Text en © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Zhang, Wen
Yue, Xiang
Lin, Weiran
Wu, Wenjian
Liu, Ruoqi
Huang, Feng
Liu, Feng
Predicting drug-disease associations by using similarity constrained matrix factorization
title Predicting drug-disease associations by using similarity constrained matrix factorization
title_full Predicting drug-disease associations by using similarity constrained matrix factorization
title_fullStr Predicting drug-disease associations by using similarity constrained matrix factorization
title_full_unstemmed Predicting drug-disease associations by using similarity constrained matrix factorization
title_short Predicting drug-disease associations by using similarity constrained matrix factorization
title_sort predicting drug-disease associations by using similarity constrained matrix factorization
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006580/
https://www.ncbi.nlm.nih.gov/pubmed/29914348
http://dx.doi.org/10.1186/s12859-018-2220-4
work_keys_str_mv AT zhangwen predictingdrugdiseaseassociationsbyusingsimilarityconstrainedmatrixfactorization
AT yuexiang predictingdrugdiseaseassociationsbyusingsimilarityconstrainedmatrixfactorization
AT linweiran predictingdrugdiseaseassociationsbyusingsimilarityconstrainedmatrixfactorization
AT wuwenjian predictingdrugdiseaseassociationsbyusingsimilarityconstrainedmatrixfactorization
AT liuruoqi predictingdrugdiseaseassociationsbyusingsimilarityconstrainedmatrixfactorization
AT huangfeng predictingdrugdiseaseassociationsbyusingsimilarityconstrainedmatrixfactorization
AT liufeng predictingdrugdiseaseassociationsbyusingsimilarityconstrainedmatrixfactorization